LIBBY BANEY BURSTEIN

FAEGRE DRINKER BIDDLE & REATH LLP · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

10 agencies contacted

Activity

filings by quarter

Works on

Health Issues 8 Pharmacy 8 Consumer Issues/Safety/Products 3 Insurance 3 Telecommunications 3

Background

Career

FAEGRE DRINKER BIDDLE & REATH LLP

Washington, DC

2024 - present

Specific issues

Issues related to extension of the National Flood Insurance Program; enactment of a safe harbor for insurers of state-legal cannabis businesses; Establishment of the National Association of Registered Agents & Brokers board; issues related to S. 2860, the SAFER Banking Act.

Insurance · 2024 Q3

Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; Domain Reform for Unlawful Drug Sellers Act (DRUGS Act); SHOP SAFE Act; S. 1080 - Cooper Davis Act.

Health Issues · 2024 Q3

Illicit prescription drug sales online; Rogue internet drug sellers; Dangers of counterfeit medicines; Risks of drug importation on patient safety; Domain name system accountability; S.3399, H.R. 6352 - Domain Reform for Unlawful Drug Sellers Act (DRUGS Act);S. 1843, H.R. 3429 - SHOPSAFE Act; S. 4858 - Cooper Davis Act.

Pharmacy · 2024 Q3

S. 936 - The Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers (INFORM Consumers) Act of 2021; H.R. 3429 - the Stopping Harmful Offers on Platforms by Screening Against Fakes in E-Commerce (SHOP SAFE) Act of 2021; S. 4858 - Cooper Davis Act.

Consumer Issues/Safety/Products · 2024 Q3

WHOIS; Communications Decency Act; Section 230 reform; S. 4858 - Cooper Davis Act.

Telecommunications · 2024 Q3

Medication safety; pharmacy regulation and licensure, drug supply chain security and combatting the opioid epidemic including ensuring MOUD access; Prescription drug monitoring programs; HR 501 Block, Report, and Suspend Suspicious Shipments Act; Ryan Haight Act/DEA rule on telehealth; HR 4531/S 2433 SUPPORT for Patients and Communities Reauthorization Act; H.R. 7513/S. 3679 Dr. Loma Breen Health Care Provider Protection Reauthorization Act.

Pharmacy · 2024 Q3